Grants and awards

KCCG staff have been awarded grants to boost their important translational research into cancer and kidney disease.
18 September 2018

Dr Mark Cowley was awarded grant in collaboration with the Children’s Cancer Institute to enrol neuroblastoma patients onto a targeted clinical trial and investigate how their tumour genomes respond to treatment.

Dr Cowley is also part of a collaboration that was awarded a MRFF Low Survival Cancers and Diseases Project Grant to for the HR-NBL2/SIOPEN high-risk neuroblastoma clinical trial in Australia. This is a randomised clinical trial combined with translational research to improve relapse prediction for high-risk neuroblastoma.

Dr Amali Mallawaarachchi and Dr Cowley, along with researchers and clinicians at the Garvan Institute and St Vincent’s Hospital, were awarded a PKD Foundation Project Grant for their work in understanding the role of genetic variation over someone’s lifetime and new mutational mechanisms in the development of polycystic kidney disease.